Harrington KJ - Search Results

1

Inflammatory microenvironment remodelling by tumour cells after radiotherapy.

McLaughlin M, Patin EC, Pedersen M, Wilkins A, Dillon MT, Melcher AA, Harrington KJ. McLaughlin M, et al. Among authors: harrington kj. Nat Rev Cancer. 2020 Apr;20(4):203-217. doi: 10.1038/s41568-020-0246-1. Epub 2020 Mar 11. Nat Rev Cancer. 2020. PMID: 32161398 Review.

2

Cancer gene therapy: developments to 2000.

Bateman AR, Harrington KJ, Melcher AA, Vile RG. Bateman AR, et al. Among authors: harrington kj. Expert Opin Investig Drugs. 2000 Dec;9(12):2799-813. doi: 10.1517/13543784.9.12.2799. Expert Opin Investig Drugs. 2000. PMID: 11093354 Review.

3

Cancer gene therapy: Part 1. Vector development and regulation of gene expression.

Harrington KJ, Bateman AR, Melcher AA, Ahmed A, Vile RG. Harrington KJ, et al. Clin Oncol (R Coll Radiol). 2002 Feb;14(1):3-16. doi: 10.1053/clon.2001.0002. Clin Oncol (R Coll Radiol). 2002. PMID: 11898782 Review. No abstract available.

4

Cancer gene therapy: Part 2. Candidate transgenes and their clinical development.

Harrington KJ, Melcher AA, Bateman AR, Ahmed A, Vile RG. Harrington KJ, et al. Clin Oncol (R Coll Radiol). 2002 Apr;14(2):148-69. doi: 10.1053/clon.2001.0004. Clin Oncol (R Coll Radiol). 2002. PMID: 12069125 Review. No abstract available.

5

Enhancing the efficacy of a weak allogeneic melanoma vaccine by viral fusogenic membrane glycoprotein-mediated tumor cell-tumor cell fusion.

Linardakis E, Bateman A, Phan V, Ahmed A, Gough M, Olivier K, Kennedy R, Errington F, Harrington KJ, Melcher A, Vile R. Linardakis E, et al. Among authors: harrington kj. Cancer Res. 2002 Oct 1;62(19):5495-504. Cancer Res. 2002. PMID: 12359759

6

Viral fusogenic membrane glycoproteins kill solid tumor cells by nonapoptotic mechanisms that promote cross presentation of tumor antigens by dendritic cells.

Bateman AR, Harrington KJ, Kottke T, Ahmed A, Melcher AA, Gough MJ, Linardakis E, Riddle D, Dietz A, Lohse CM, Strome S, Peterson T, Simari R, Vile RG. Bateman AR, et al. Among authors: harrington kj. Cancer Res. 2002 Nov 15;62(22):6566-78. Cancer Res. 2002. PMID: 12438252

7

Radiation-induced cell death and dendritic cells: potential for cancer immunotherapy?

Hatfield P, Merrick A, Harrington K, Vile R, Bateman A, Selby P, Melcher A. Hatfield P, et al. Clin Oncol (R Coll Radiol). 2005 Feb;17(1):1-11. doi: 10.1016/j.clon.2004.06.014. Clin Oncol (R Coll Radiol). 2005. PMID: 15714922 Review.

8

Immunosuppressive effects of radiation on human dendritic cells: reduced IL-12 production on activation and impairment of naive T-cell priming.

Merrick A, Errington F, Milward K, O'Donnell D, Harrington K, Bateman A, Pandha H, Vile R, Morrison E, Selby P, Melcher A. Merrick A, et al. Br J Cancer. 2005 Apr 25;92(8):1450-8. doi: 10.1038/sj.bjc.6602518. Br J Cancer. 2005. PMID: 15812550 Free PMC article.

9

Fusogenic membrane glycoprotein-mediated tumour cell fusion activates human dendritic cells for enhanced IL-12 production and T-cell priming.

Errington F, Jones J, Merrick A, Bateman A, Harrington K, Gough M, O'Donnell D, Selby P, Vile R, Melcher A. Errington F, et al. Gene Ther. 2006 Jan;13(2):138-49. doi: 10.1038/sj.gt.3302609. Gene Ther. 2006. PMID: 16136162

10

Combining radiation and cancer gene therapy: a potential marriage of physical and biological targeting?

Hingorani M, White CL, Agrawal VK, Vidal L, Melcher A, Harrington KJ. Hingorani M, et al. Among authors: harrington kj. Curr Cancer Drug Targets. 2007 Jun;7(4):389-409. doi: 10.2174/156800907780809787. Curr Cancer Drug Targets. 2007. PMID: 17979632 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

409 results

Search Page